Federal loans for medical students are now capped at $50,000 a year and $200,000 total, and the Grad PLUS program that let students borrow up to their full cost of attendance is gone for new borrowers as of July 1. The coverage has focused on the gap, and the gap is real: the median four-year cost of attendance for the class of 2026 was $297,745 at public schools and $408,150 at private schools, so federal borrowing no longer covers the bill at either.

But the borrowing shortfall is the visible problem, and it is not the one most likely to change who becomes a doctor. Physicians are unlike every other professional borrower in one specific way, and that difference sits in the years right after graduation.

Why residency makes physicians a special case

A newly minted lawyer with heavy debt goes to work at a law firm. A newly minted physician goes to residency, which is mandatory, lasts three to seven years depending on specialty, and pays roughly $60,000 to $75,000 a year regardless of how much debt the resident is carrying. That is not a market wage. It is a training stipend, set by a system the resident cannot negotiate with and cannot skip, because board certification requires it.

So the medical debt model has always had a structural problem: peak debt arrives at the exact moment of minimum income, and stays there for years. Monthly payments on a $300,000 balance at market rates would exceed $3,000 a month, which is more than half a resident's gross pay.

Federal loans solved this. Income-driven repayment set payments as a percentage of discretionary income, which meant a resident earning $65,000 paid a manageable amount and the balance waited. Public Service Loan Forgiveness went further, wiping out remaining balances after ten years of qualifying nonprofit or public work, which for many physicians included residency itself. The debt was enormous, and the repayment structure made it survivable.

That is the piece that broke. Private loans, which students must now use to cover the gap, generally require full payments on a fixed schedule with no income-based adjustment and no forgiveness. A physician in residency with a substantial private balance faces payments calculated against an attending physician's future salary while earning a trainee's current one. The caps determine how much students can borrow federally. The repayment terms determine whether they can survive the years immediately after.

The theory behind the caps, and where it runs into this market

The policy rationale deserves a fair hearing, because it is not arbitrary. The argument is that unlimited federal lending let schools raise tuition without consequence, since students could always borrow more, and that capping federal loans forces institutions to contain costs. There is real economic literature behind this idea, and the correlation is suggestive: between 2008 and 2020, the annual cost of medical school rose 38% while the share of students using Grad PLUS loans climbed from 13% to nearly half.

The mechanism only works, though, if schools face competitive pressure to cut prices, and medical education is close to the least competitive market imaginable. Applicants vastly outnumber seats. Accreditation and clinical training capacity limit how fast schools can expand. A school that rejects most of its applicants has no reason to discount, because there is no risk of empty seats. Price pressure works where demand is elastic and supply can grow. Here demand is inelastic and supply is capped by accreditation, which means the likelier adjustment is not lower tuition but a different mix of students, specifically those who can cover the gap.

The filter this creates

If the gap between the $200,000 cap and a $300,000 or $400,000 cost of attendance gets filled by private credit, then access to medical school starts running partly through credit checks and co-signers rather than academic qualification. Private loans are credit-based. A student with a parent who can co-sign gets a rate; a student without one may not get the loan at all.

That is a filter on family finances, and its effects are not evenly distributed. More than three-quarters of Latino medical students, 76%, rely on federal loans to cover the cost of attendance, which means the population most dependent on the program being cut is also among the most underrepresented in the physician workforce.

The second-order effect on where doctors go

Here is the consequence that will take longest to show up and may matter most.

Debt structure shapes specialty choice. When repayment was income-driven and forgiveness was available for public and nonprofit service, a graduate could choose primary care, or a rural practice, or a community health center, without the debt making that choice financially ruinous. PSLF in particular functioned as a workforce policy, subsidizing exactly the underserved and lower-paying settings the system has trouble staffing.

Private debt removes that. A physician with a large private balance requiring full payments has a strong financial reason to choose the highest-paying specialty available and to avoid nonprofit and underserved settings, because those loans do not qualify for forgiveness. The pressure runs precisely against primary care, rural medicine, and community health, which is where the shortages are already worst. The AAMC projects a shortfall of up to 86,000 physicians by 2036, driven by an aging population and a workforce in which a large share is already over 55.

There is a related detail worth naming, because it cuts the same direction. Nurse practitioner and physician assistant programs are classified as general graduate programs, not professional ones, which caps them at $20,500 a year and $100,000 total. Those are the clinicians the system relies on to absorb primary care demand that physicians cannot meet.

What is actually true right now

A few things are worth separating from the alarm.

The caps are not retroactive in the usual sense. Students who received a federal disbursement for their program before July 1, 2026 and stay continuously enrolled in the same program at the same institution can generally keep borrowing under the old rules for up to three more years, though that legacy pathway sunsets entirely by June 30, 2029. Changing programs or schools ends it.

The annual professional limit of $50,000 is actually higher than the old $20,500 Direct Unsubsidized cap. The loss is Grad PLUS, not the base loan, and for students at lower-cost public schools with scholarships, federal borrowing may still cover most of the bill. And the gap is not automatically catastrophic. Scholarships, service programs like the National Health Service Corps, military scholarships, and school-specific aid all reduce it.

The question the policy will answer

The stated goal is to force costs down. The likelier outcome, given a market where applicants outnumber seats and supply cannot expand quickly, is that the cost stays roughly where it is and the financing shifts to private credit, with the composition of who enrolls shifting alongside it.

The thing to watch over the next several years is not tuition, which will move slowly if at all. It is the mix: whether medical school classes tilt toward students with family wealth, and whether graduates tilt toward high-paying specialties and away from the primary care and underserved settings that federal repayment programs used to make financially viable. Those are measurable, and they will show up in AAMC matriculant data and residency match patterns well before any tuition line moves.

Medical school debt in the United States was never mainly a question of whether students could borrow enough. It was a question of whether they could survive repayment during the years when their training kept their income artificially low. The federal system had an answer to that. What replaces it does not, and that is the part of this change most likely to alter who practices medicine and where.

Further reading